We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

AGILENT

Agilent provides laboratories worldwide with instruments, services, consumables, applications and expertise, enabling... read more Featured Products: More products

Download Mobile App




Microarray Diagnostic Tool Helps Diagnose Valley Fever

By LabMedica International staff writers
Posted on 05 Aug 2014
Print article
Image: Photomicrograph of Coccidioides immitis in lung tissue showing as large, irregularly sized thick walled spherules (Photo courtesy of Dr. William McDonald, MD).
Image: Photomicrograph of Coccidioides immitis in lung tissue showing as large, irregularly sized thick walled spherules (Photo courtesy of Dr. William McDonald, MD).
Valley fever (VF) is a fungal respiratory infection and can be acquired when microscopic spores of the soil-dwelling fungus are inhaled and VF is difficult to diagnose partly because symptoms are confounded with other community-acquired pneumonias.

Two forms of the fungus exist, Coccidioides immitis and C. posadasii and confirmatory diagnostics detect immunoglobulin M (IgM) and IgG antibodies against Coccidioidal antigens via immunodiffusion (ID). However the false negative rate can be as high as 50% to 70% with 5% of symptomatic patients never showing detectable antibody levels.

Scientists at Arizona State University (Temple, AZ, USA) obtained a cohort of 55 VF samples and a blinded test set of 67 samples as de-identified human patient sera. In order to test whether different infections are discernable, patient sera representing 19 Aspergillus fumigatus, 19 Mycoplasma pneumoniae, and 19 Chlamydia pneumoniae samples were processed alongside 18 VF and 31 healthy sera.

The microarray platform consists of a glass slide imprinted with 10,000 (10K) peptides. Each peptide consists of a string of 20 amino acids, randomly arranged. The power of the technology resides in the fact that the randomly generated peptides are not based on natural antigens to Coccidioides or indeed, any disease. They are "unbiased" to the nature of particular disease antibodies and can therefore act as a sort of universal diagnostic. The peptides are spotted onto standard slides using noncontact piezo printer. The slides were scanned on the SureScan Microarray C Scanner (Agilent Technologies; Santa Clara, CA, USA). Once an immunosignature for VF was established using the 10K peptide microarray, a smaller diagnostic array was composed from relevant diagnostic peptides. This smaller 96-peptide array was then tested for accuracy against the current immunodiffusion diagnostic standard.

The 10K peptide array successfully distinguished Valley fever from three other infections, with 98% accuracy. Impressively, the method also was able to classify false negative VF patients in a blinded test, with 100% accuracy, easily outpacing existing immunodiffusion methods, which could only identify 28% of false negatives. The smaller, 96 peptide diagnostic array showed less specificity than the 10K peptide array in terms of identifying false negatives. The authors propose that the larger 10K peptide array be used in initial screenings, followed by subarrays with reduced complements of carefully selected peptides, used for clinical diagnosis. The study was published ahead of print on June 25, 2014, in the journal Clinical and Vaccine Immunology.

Related Links:

Arizona State University
Agilent Technologies 


Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Fecal DNA Extraction Kit
QIAamp PowerFecal Pro DNA Kit
New
TORCH Infections Test
TORCH Panel

Print article

Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.